Mendel Capital Management’s Clorox CLX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$372K Sell
3,901
-777
-17% -$74.6K 0.17% 75
2026
Q1
$485K Buy
+4,678
New +$530K 0.24% 66
2025
Q3
$524K Buy
4,246
+346
+9% +$42.9K 0.27% 61
2025
Q2
$468K Buy
3,900
+176
+5% +$23.5K 0.27% 65
2025
Q1
$548K Buy
3,724
+185
+5% +$28.3K 0.33% 61
2024
Q4
$575K Buy
3,539
+278
+9% +$45.5K 0.35% 56
2024
Q3
$531K Buy
3,261
+267
+9% +$39.6K 0.33% 61
2024
Q2
$409K Buy
2,994
+59
+2% +$8.19K 0.26% 69
2024
Q1
$449K Sell
2,935
-144
-5% -$21.5K 0.3% 64
2023
Q4
$439K Sell
3,079
-263
-8% -$35.1K 0.32% 64
2023
Q3
$438K Buy
3,342
+12
+0.4% +$1.82K 0.36% 58
2023
Q2
$530K Buy
3,330
+89
+3% +$14.4K 0.42% 50
2023
Q1
$513K Buy
3,241
+1,656
+104% +$248K 0.46% 43
2022
Q4
$222K Sell
1,585
-128
-7% -$18.2K 0.23% 64
2022
Q3
$220K Buy
1,713
+11
+0.6% +$1.59K 0.26% 58
2022
Q2
$240K Buy
1,702
+112
+7% +$16K 0.27% 59
2022
Q1
$221K Buy
1,590
+236
+17% +$36.2K 0.21% 64
2021
Q4
$236K Buy
+1,354
New +$226K 0.22% 64

Other funds holding CLX

Mendel Capital Management's CLX Position: Q2 2026 in Review

Mendel Capital Management reduced its Clorox (CLX) stake by 17% in Q2 2026, selling an estimated $74.6K and leaving 3,901 shares worth $372K. The position accounts for 0.17% of the portfolio, ranked #75.

Mendel Capital Management first reported a position in CLX in Q4 2021 and has held it in 18 quarters since. The position peaked at $575K in Q4 2024. 434 funds tracked by Wall St. Rank hold CLX as of Q2 2026.

  • Mendel Capital Management held 3,901 shares of Clorox worth $372K as of Q2 2026.
  • Mendel Capital Management sold 777 Clorox shares in Q2 2026, an estimated $74.6K.
  • Clorox made up 0.17% of Mendel Capital Management's portfolio in Q2 2026, its #75 holding.
  • Mendel Capital Management first reported a position in Clorox in Q4 2021 and has held it in 18 quarters since.
  • Mendel Capital Management's Clorox position peaked at $575K in Q4 2024.
  • 434 funds tracked by Wall St. Rank held Clorox as of Q2 2026.

Based on Mendel Capital Management's 13F filing for Q2 2026, filed 21 Jul 2026.